|Bid||2,600.00 x 0|
|Ask||2,601.50 x 0|
|Day's range||2,595.50 - 2,618.50|
|52-week range||2,422.50 - 2,961.50|
|Beta (5Y monthly)||0.73|
|PE ratio (TTM)||9.63|
|Earnings date||28 Jul 2021|
|Forward dividend & yield||2.16 (8.30%)|
|Ex-dividend date||23 Dec 2021|
|1y target est||3,499.50|
Altria (MO) strives to expand IQOS and on! amid consumers' rising preference on low-risk tobacco alternatives. Moreover, strong pricing for tobacco products is driving revenues.
The FDA said the approval came after analysis of data from the manufacturer that showed that using Vuse's tobacco-flavored products could help users reduce exposure to harmful chemicals emitted by combustible cigarettes. "Today’s order represents an important moment for Reynolds," a British American Tobacco spokesperson said, referring to the company's American unit R.J. Reynolds Vapor Co, which had filed for Vuse's marketing approval. The FDA granted permission to R.J. Reynolds to market its Vuse Solo closed electronic nicotine-delivery device and two accompanying tobacco-flavored e-liquid pods, which have a nicotine strength of 4.8%, which is roughly equivalent to a pack of cigarettes.
British American Tobacco will cease all operations in military-ruled Myanmar and withdraw by the end of this year, the company said on Tuesday, the latest Western firm to pull out of the country in turmoil since a February coup. Responding to a query from Reuters about the status of its operations in the Southeast Asian country, the company said the decision was taken having assessed the long-term viability of its Myanmar business. "Like any global company, we continuously evaluate our operations around the world," the company said.